急性心肌梗死患者直接经皮冠状动脉介入术中再灌注心律失常临床分析被引量：20

下载PDF

导出

摘要目的分析急性心肌梗死(AMI)患者行直接经皮冠状动脉介入治疗术(PCI)中再灌注性心律失常的临床特点及预后。方法回顾性分析2006年1月—2009年6月210例AMI患者行PCI治疗的病史资料。结果 135例(64.3%)患者发生再灌注性心律失常;前壁梗死较下后壁梗死发生快速型心律失常较多,但无统计学意义;下后壁梗死较前壁梗死发生缓慢型心律失常多见(P<0.01)。6 h内开通冠状动脉者再灌注心律失常发生率明显高于6 h^12 h开通者(P<0.01),且严重再灌注心律失常较多见。结论再灌注心律失常在直接PCI术中发生率较高;类型与心肌梗死部位有关,再灌注的时间影响再灌注心律失常的发生率。

作者薛伟珍杨丽峰马登峰姜兆秀王晨宁丽君

机构地区太原市中心医院

出处《中西医结合心脑血管病杂志》 2010年第9期1140-1141,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

关键词急性心肌梗死直接经皮冠状动脉介入术再灌注心律失常

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献10

1Weaver WD,Simes RJ,Betriu A,etal. Comparison of primary coronary angioplasty and intravenou sthrombolytic therapy for acute myocardialinfarction. A quantitative review[J].JAMA,1997,278: 2093 -2098.
2张嘉莹,朱中玉,李牧蔚,陈岩,王现青.青年急性心肌梗死患者脂蛋白(a)水平的变化及其意义[J].临床心血管病杂志,2002,18(10):500-502. 被引量：248
3刘桂蕊张恩清孙美等.急性心肌梗死再灌注心律失常.临床荟萃,2003,15(1):45-45.
4Reyes M, Dudek A, J ahagirdar B, et a l. Origin of endothelial progenitors in human postnatal bone marrow[J]. Clin Invest, 2002, 109(3):337 -346.
5陈在嘉.我国急性心肌梗塞再灌注治疗进展[J].中华心血管病杂志,1993,21(6):353-354. 被引量：20
6Birnbaum Y, Leor J, Kloner RA. Pathobiology and Clinical Impact of Reperfusion Injury[J]. J Thromb Thrombolysis, 2004,4:185 - 195.
7李华珍,王红,梁文武.急性心肌梗死急诊行经皮冠状动脉介入术中再灌注心律失常的临床研究[J].中华实用诊断与治疗杂志,2009,23(6):608-609. 被引量：19
8Goldberg S, Greenspon AJ, Urban PI., et al. Reperfusion arrhythmia:A marker of restoration of anterograde flow during intracoronary thrombolysis for acute myocardial disease[J]. Am Heart J 1983,105:26 - 32.
9Subodh V, Fedak PW,Weisel RD,et al. Fundamentals of Reperfusion Injury for the Clinical Cardiologist[J]. Circulation, 2002, 105:2332 - 2336.
10Manning AS, Hearse DJ. Reperfusion - induced arrhythmias Mechanisms and Prevention[J]. J Mol Cell Cardiol, 1984, 16: 497.

二级参考文献12

1潘静薇,魏盟,李京波,陆志刚,马士新,魏钧伯.急性心肌梗死患者住院期死亡相关因素变化分析[J].实用诊断与治疗杂志,2007,21(4):280-282. 被引量：8
2Polonski L, Gasior M, Wasilewski J, et al. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction[J]. Am Heart J,2003,145(5):855-858.
3Yoshida Y, Hirai M, Yamada T, et al. Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias: evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias[J]. Circulation, 2000,101 (6) : 624-630.
4李跃洲.老年与青年急性心肌梗死患者危险因素和心理状态分析[J].实用诊断与治疗杂志,2007,21(8):638-639. 被引量：13
5Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
6Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
7Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
8Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.
9Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280.
10Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150.